68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership

Giuseppe Carlucci; Robin Ippisch; Roger Slavik; Ashley Mishoe; Joseph Blecha; Shaojun Zhu

doi:10.2967/jnumed.120.260455

OtherState-of-the-Art (Invitation Only)

Open Access

⁶⁸Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership

Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha and Shaojun Zhu

Journal of Nuclear Medicine December 2020, jnumed.120.260455; DOI: https://doi.org/10.2967/jnumed.120.260455

Giuseppe Carlucci

1 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robin Ippisch

2 Department of Radiology and Biomedical Imaging, University of California, San Francisco, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roger Slavik

1 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ashley Mishoe

3 Department of Radiology and Biomedical Imaging, University of California, San Francisco,, United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joseph Blecha

2 Department of Radiology and Biomedical Imaging, University of California, San Francisco, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shaojun Zhu

1 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 2

February 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

⁶⁸Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership

Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha, Shaojun Zhu

Journal of Nuclear Medicine Dec 2020, jnumed.120.260455; DOI: 10.2967/jnumed.120.260455

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

⁶⁸Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership

Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha, Shaojun Zhu

Journal of Nuclear Medicine Dec 2020, jnumed.120.260455; DOI: 10.2967/jnumed.120.260455

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

State-of-the-Art (Invitation Only)

The navigating and de-risking role of ⁸⁹Zr-immuno-PET in the development of biopharmaceuticals
State-of-the-Art: FAPI PET/CT-Will it end the hegemony of FDG in oncology?

Show more State-of-the-Art (Invitation Only)

Clinical (Oncology: GU)

Detection of Early Progression with ¹⁸F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY
A novel time-activity information sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: application in SPECT/CT imaging post-¹⁷⁷Lu-DOTATATE

Show more Clinical (Oncology: GU)

Keywords

Oncology: GU
PET/CT
radiochemistry
radiopharmaceuticals
68Ga-PSMA-11
approval
FDA
new drug application

Main menu

User menu

Search

⁶⁸Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

State-of-the-Art (Invitation Only)

Clinical (Oncology: GU)

Similar Articles

Keywords